Year 2024 / Volume 116 / Number 4
Letter
KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena?

236-237

DOI: 10.17235/reed.2023.9926/2023

César Gutiérrez Pérez, Carmen Blanco Abad, Gadea Hontoria Bautista, Patricia Saiz López, Inmaculada Rodríguez Ledesma, Noelia Espinosa Cabria, Irene Ramos Reguera, Ana María López Muñoz,

Abstract
The oncogenic KRAS mutation is associated with increased tissue factor expression and thus hypercoagulability. In this regard, numerous studies published in the last decade have shown that KRAS mutations are an important risk factor for the development of thromboembolic phenomena in neoplasms of the digestive tract, such as colorectal cancer. On the other hand, some recently published studies suggest that KRAS mutations are also associated with an increased risk of developing thromboembolic phenomena in pancreatic cancer. Based on these premises, we have conducted a single-centre retrospective study on a cohort of patients with pancreatic cancer. Our aim is to demonstrate whether there is an association between the presence of KRAS mutations in our cohort of pancreatic cancer patients and an increased risk of developing thromboembolic phenomena.
Share Button
New comment
Comments
No comments for this article
References
1. Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007; 110(10): 2339-46
2. Khorana AA. Risk assessment for cancer-associated thrombosis: what is the best approach?. Thromb Res 2012; 129 Suppl 1: S10-S15
3. Prandoni P, Falanga A, Piccioli A, et al. Cancer and venous thromboembolism. Lancet Oncol 2005; 6(6): 401-10
4. Ades S, Kumar S, Alam M, et al. Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorrectal cancer. J Thromb Haemost 2015; 13(6): 998-1003
5. Serrano E, Saavedra EI, Padilla M, et al. Kras mutation as a risk factor for venous thromboembolism in patients with metastatic pancreatic cancer. J Clin Oncol 2021; 39: 15-suppl, e16267-e16267
Citation tools
Gutiérrez Pérez C, Blanco Abad C, Hontoria Bautista G, Saiz López P, Rodríguez Ledesma I, Espinosa Cabria N, et all. KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena?. 9926/2023


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1117 visits.
This article has been downloaded 40 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 31/08/2023

Accepted: 13/09/2023

Online First: 29/09/2023

Published: 09/04/2024

Article Online First time: 29 days

Article editing time: 222 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2024 y Creative Commons. The Spanish Journal of Gastroenterology